Investigation of the mechanism(s) involved in decreasing increased fibrinogen activity in hyperglycemic conditions using L-lysine supplementation

Thrombosis Research
Hossein MirmiranpourAbbas Kebriaeezadeh

Abstract

Fibrinogen is a plasma glycoprotein that participates in the hemostasis system. Its malfunction has been reported as a consequence of diabetic complications. In this study, the inhibitory effect of L-Lysine (Lys) on the nonenzymatic glycation of fibrinogen was investigated in both in vitro and in vivo conditions. Fibrinogen was incubated with glucose in the presence or absence of Lys. Then, its structure was studied by fluorescence spectroscopy, circular dichroism, and electrophoresis. The Clauss method was used to determine fibrinogen activity. In addition, one of the two groups of type 2 diabetic patients receiving ordinary treatment was additionally treated with Lys for 3 months. Fibrinogen activity and some other parameters were evaluated in their plasma. The results indicated increases in the activity of glycated fibrinogen in both of the in vivo and in vitro experiments. Advanced glycation end products were increased by time, as shown using fluorometry in both the plasma of the diabetic patients and the incubation medium of protein with glucose. The circular dichroism spectra showed some changes in the fibrinogen secondary and tertiary structures after glycation. The electrophoretic mobility of the glycated fibrinogen cha...Continue Reading

References

Jan 1, 1989·Annals of Clinical Biochemistry·M R HammerR D Leslie
Aug 1, 1987·Experimental and Clinical Endocrinology·S KrantzE Teuscher
Jun 1, 1996·Cell Stress & Chaperones·W J Welch, C R Brown
Nov 24, 1998·Metabolism: Clinical and Experimental·K YanagisawaT Koike
Jan 27, 1999·Journal of Pharmacological and Toxicological Methods·C BaiM A Matthay
May 26, 2001·Biochemical and Biophysical Research Communications·H ZoellnerG Lynch
May 29, 2002·Diabetes Care·Kathryn C B TanKaren S L Lam
Oct 22, 2003·Archives of Biochemistry and Biophysics·Margo P Cohen
Apr 22, 2004·PharmacoEconomics·Greg L Plosker, David P Figgitt
Dec 14, 2004·Annals of Clinical Biochemistry·Gordon D O LoweIan J Mackie
Dec 29, 2004·Biophysical Chemistry·Subhrojit SenAbhay Sankar Chakraborti
Jan 12, 2005·Clinical Biochemistry·Annunziata LapollaDomenico Fedele
Aug 17, 2005·Journal of Thrombosis and Haemostasis : JTH·M W Mosesson
Nov 29, 2005·Archives of Biochemistry and Biophysics·Deanna L MendezRaymond M Esquerra
Sep 21, 2007·Diabetes/metabolism Research and Reviews·A JafarnejadS Banasadegh
Apr 4, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Shahar RotemAmram Mor
Jul 29, 2008·American Journal of Respiratory and Critical Care Medicine·Karen S McCoyA Bruce Montgomery
Mar 20, 2009·Biomacromolecules·Anne-Claude Couffin-HoarauMichel Vert
Apr 17, 2009·Bioinformatics·Michael RyanRachel Karchin
Mar 20, 2010·Veterinary Parasitology·Gürbüz DaşMatthias Gauly
Dec 15, 2010·Journal of Biomolecular Structure & Dynamics·Rahman Rahmanpour, S Zahra Bathaie
Sep 2, 2011·The Protein Journal·S Zahra BathaieS Zahra Moosavi-Nejad

❮ Previous
Next ❯

Citations

Sep 2, 2015·Journal of Biomolecular Structure & Dynamics·Govindarajan Prasanna, N T Saraswathi
Feb 28, 2019·Journal of Lasers in Medical Sciences·Hossein MirmiranpourAhmad Amjadi
Jan 10, 2020·Arteriosclerosis, Thrombosis, and Vascular Biology·Judith J de VriesMoniek P M de Maat

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.